These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 21199182

  • 21. Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide.
    Leitch MM, Sherman WH, Brannagan TH.
    Muscle Nerve; 2013 Feb; 47(2):292-6. PubMed ID: 23168526
    [Abstract] [Full Text] [Related]

  • 22. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
    Caudie C, Vial C, Petiot P, Bancel J, Lombard C, Gonnaud PM.
    Ann Biol Clin (Paris); 2001 Feb; 59(5):567-77. PubMed ID: 11602387
    [Abstract] [Full Text] [Related]

  • 23. A Severe Form of M - protein Negative Distal Acquired Demyelinating Symmetric Neuropathy.
    Ong TL, Goh KJ, Shahrizaila N, Wong KT, Tan CY.
    Neurol India; 2019 Feb; 67(6):1532-1535. PubMed ID: 31857554
    [Abstract] [Full Text] [Related]

  • 24. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
    Cocito D, Ciaramitaro P, Isoardo G, Barbero P, Migliaretti G, Pipieri A, Proto G, Quadri R, Bergamasco B, Durelli L.
    J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
    [Abstract] [Full Text] [Related]

  • 25. Characterization of neuropathies associated with elevated IgM serum levels.
    Goldfarb AR, Sander HW, Brannagan TH, Magda P, Latov N.
    J Neurol Sci; 2005 Feb 15; 228(2):155-60. PubMed ID: 15694197
    [Abstract] [Full Text] [Related]

  • 26. Is distal motor and/or sensory demyelination a distinctive feature of anti-MAG neuropathy?
    Lozeron P, Ribrag V, Adams D, Brisset M, Vignon M, Baron M, Malphettes M, Theaudin M, Arnulf B, Kubis N.
    J Neurol; 2016 Sep 15; 263(9):1761-70. PubMed ID: 27314957
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Distal acquired demyelinating symmetric neuropathy.
    Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ.
    Neurology; 2000 Feb 08; 54(3):615-20. PubMed ID: 10680792
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Polyneuropathy associated with IgM vs IgG monoclonal gammopathy: comparison between clinical and electrophysiological findings.
    Vrethem M, Reiser N, Lauermann C, Svanborg E.
    Acta Neurol Scand; 2010 Jul 08; 122(1):52-7. PubMed ID: 20003083
    [Abstract] [Full Text] [Related]

  • 31. Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy.
    Lucke IM, Wieske L, van der Kooi AJ, van Schaik IN, Eftimov F, Verhamme C.
    J Peripher Nerv Syst; 2019 Jun 08; 24(2):174-179. PubMed ID: 31090121
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
    Wadwekar V, Kalita J, Misra UK.
    Neurol India; 2011 Jun 08; 59(5):664-8. PubMed ID: 22019647
    [Abstract] [Full Text] [Related]

  • 35. Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy.
    Chan YC, Allen DC, Fialho D, Mills KR, Hughes RA.
    J Neurol Neurosurg Psychiatry; 2006 Jan 08; 77(1):114-6. PubMed ID: 16361609
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Polyneuropathy associated with monoclonal gammapathy: treatment perspectives].
    Leger JM, Chassande B, Bombelli F, Viala K, Musset L, Neil J.
    Bull Acad Natl Med; 2009 May 08; 193(5):1099-110; discussion 1110-1. PubMed ID: 20120390
    [Abstract] [Full Text] [Related]

  • 38. [Rapid improvement by rituximab treatment in a case of demyelinating polyneuropathy with anti-myelin-associated glycoprotein antibody].
    Motoyama R, Yamakawa K, Suzuki S, Kusunoki S, Tanaka M.
    Rinsho Shinkeigaku; 2011 Oct 08; 51(10):761-4. PubMed ID: 22019868
    [Abstract] [Full Text] [Related]

  • 39. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
    Dalakas MC.
    J Peripher Nerv Syst; 2012 May 08; 17 Suppl 2():34-9. PubMed ID: 22548621
    [Abstract] [Full Text] [Related]

  • 40. [Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021].
    Kuwabara S.
    Rinsho Shinkeigaku; 2024 May 24; 64(5):321-325. PubMed ID: 38644208
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.